Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease
- 1 September 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (9), 1979-1984
- https://doi.org/10.1002/eji.1830260902
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Human FceRII. Molecular, Biological and Clinical AspectsPublished by S. Karger AG ,2015
- Role of IgE in atopic dermatitisCurrent Opinion in Immunology, 1993
- CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodiesEuropean Journal of Immunology, 1993
- Co‐crosslinking FcϵRII/CD23 and B cell surface immunoglobulin modulates B cell activationEuropean Journal of Immunology, 1992
- Affinity-purified soluble FcϵRII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanismImmunology Letters, 1991
- CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.The Journal of Experimental Medicine, 1990
- Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgEJournal of Allergy and Clinical Immunology, 1990
- Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.The Journal of Experimental Medicine, 1990
- IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.Proceedings of the National Academy of Sciences, 1988
- Potentiation of human immunoglobulin E synthesis by plasma immunoglobulin E binding factors from patients with the hyperimmunoglobulin E syndrome.JCI Insight, 1986